Alternative G protein coupling and biased agonism: New insights into melanocortin-4 receptor signalling

[1]  T. Webb,et al.  Minireview: the melanocortin 2 receptor accessory proteins. , 2010, Molecular endocrinology.

[2]  J. Hoyer,et al.  Modulation of blood pressure by central melanocortinergic pathways. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  N. Heveker,et al.  Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands , 2009, Journal of Pharmacology and Experimental Therapeutics.

[4]  M. Hollenberg,et al.  Agonist-Biased Signaling via Proteinase Activated Receptor-2: Differential Activation of Calcium and Mitogen-Activated Protein Kinase Pathways , 2009, Molecular Pharmacology.

[5]  A. B. Pérez-Oliva,et al.  Mahogunin Ring Finger-1 (MGRN1) E3 Ubiquitin Ligase Inhibits Signaling from Melanocortin Receptor by Competition with Gαs* , 2009, The Journal of Biological Chemistry.

[6]  S. Nickolls,et al.  The effect of assay formats on the estimation of melanocortin agonist affinity and efficacy using the operation model of agonism. , 2009, European journal of pharmacology.

[7]  T. Gudermann,et al.  Pertussis Toxin-sensitive Signaling of Melanocortin-4 Receptors in Hypothalamic GT1-7 Cells Defines Agouti-related Protein as a Biased Agonist* , 2009, The Journal of Biological Chemistry.

[8]  P. M. Hinkle,et al.  Opposite Effects of the Melanocortin-2 (MC2) Receptor Accessory Protein MRAP on MC2 and MC5 Receptor Dimerization and Trafficking* , 2009, The Journal of Biological Chemistry.

[9]  M. Mulholland,et al.  Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling , 2009, Peptides.

[10]  M. Elphick,et al.  MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family , 2009, Proceedings of the National Academy of Sciences.

[11]  A. Grüters,et al.  Heterodimerization of Hypothalamic G-Protein-Coupled Receptors Involved in Weight Regulation , 2009, Obesity Facts.

[12]  P. M. Hinkle,et al.  Structure and function of the melanocortin2 receptor accessory protein (MRAP) , 2009, Molecular and Cellular Endocrinology.

[13]  R. Ostrom,et al.  The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae. , 2009, Cellular signalling.

[14]  Michel Bouvier,et al.  Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. , 2008, The Journal of biological chemistry.

[15]  R. Ostrom,et al.  Adenylyl cyclase type 6 overexpression selectively enhances β-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  A. N. van den Pol,et al.  Agouti-Related Peptide and MC3/4 Receptor Agonists Both Inhibit Excitatory Hypothalamic Ventromedial Nucleus Neurons , 2008, The Journal of Neuroscience.

[17]  A. Schonbrunn.  Selective agonism in somatostatin receptor signaling and regulation , 2008, Molecular and Cellular Endocrinology.

[18]  M. Bouvier,et al.  Conformational Rearrangements and Signaling Cascades Involved in Ligand-Biased Mitogen-Activated Protein Kinase Signaling through the β1-Adrenergic Receptor , 2008, Molecular Pharmacology.

[19]  R. Palmiter,et al.  Starvation after AgRP neuron ablation is independent of melanocortin signaling , 2008, Proceedings of the National Academy of Sciences.

[20]  T. Luger,et al.  -Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases , 2008 .

[21]  G. McKnight,et al.  Disruption of the RIIβ subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice , 2008, Proceedings of the National Academy of Sciences.

[22]  M. Low,et al.  In Vivo Evidence for Inverse Agonism of Agouti-Related Peptide in the Central Nervous System of Proopiomelanocortin-Deficient Mice , 2008, Diabetes.

[23]  T. Kenakin.  Functional Selectivity through Protean and Biased Agonism: Who Steers the Ship? , 2007, Molecular Pharmacology.

[24]  Y. Iwakura,et al.  Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis , 2007, Proceedings of the National Academy of Sciences.

[25]  K. Yuyama,et al.  Translocation of Activated Heterotrimeric G Protein Gαo to Ganglioside-enriched Detergent-resistant Membrane Rafts in Developing Cerebellum* , 2007, Journal of Biological Chemistry.

[26]  M. Michel,et al.  Ligand-Directed Signaling: 50 Ways to Find a Lover , 2007, Molecular Pharmacology.

[27]  D. Daniels,et al.  Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation , 2007, Regulatory Peptides.

[28]  H. Vogel,et al.  A FRET map of membrane anchors suggests distinct microdomains of heterotrimeric G proteins , 2007, Journal of Cell Science.

[29]  M. Bouvier,et al.  The evasive nature of drug efficacy: implications for drug discovery. , 2007, Trends in pharmacological sciences.

[30]  K. Wada,et al.  Melanocortin receptor 4 is induced in nerve‐injured motor and sensory neurons of mouse , 2007, Journal of neurochemistry.

[31]  M. Mori,et al.  The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. , 2007, The Journal of endocrinology.

[32]  F. Denaro,et al.  Activation and Endocytic Internalization of Melanocortin 3 Receptor in Neuronal Cells , 2007, Annals of the New York Academy of Sciences.

[33]  S. Redmann,et al.  AgRP-deficiency could lead to increased lifespan. , 2006, Biochemical and biophysical research communications.

[34]  T. Gudermann,et al.  The Natural Inverse Agonist Agouti-related Protein Induces Arrestin-mediated Endocytosis of Melanocortin-3 and -4 Receptors* , 2006, Journal of Biological Chemistry.

[35]  Mi-Ja Kim,et al.  Positive association of obesity with single nucleotide polymorphisms of syndecan 3 in the Korean population. , 2006, The Journal of clinical endocrinology and metabolism.

[36]  M. Mulholland,et al.  Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase , 2006, Peptides.

[37]  M. Mulholland,et al.  Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons. , 2006, The Journal of surgical research.

[38]  T. Meitinger,et al.  Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. , 2006, The Journal of clinical endocrinology and metabolism.

[39]  Xiaorong Zhu,et al.  Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. , 2006, Endocrinology.

[40]  D. Clegg,et al.  A role for syndecan-3 in the melanocortin regulation of energy balance , 2006, Peptides.

[41]  A. Grüters,et al.  MC4R oligomerizes independently of extracellular cysteine residues , 2006, Peptides.

[42]  S. O’Rahilly,et al.  A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. , 2006, Cell metabolism.

[43]  M. Tschöp,et al.  A role for β-melanocyte-stimulating hormone in human body-weight regulation , 2006 .

[44]  A. Murphy,et al.  Agouti-related protein-deficient mice display an age-related lean phenotype. , 2005, Cell metabolism.

[45]  Robert A. McGovern,et al.  Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure , 2005, Cell.

[46]  R. Lefkowitz,et al.  Seven-Transmembrane Receptor Signaling Through β-Arrestin , 2005, Science's STKE.

[47]  R. Palmiter,et al.  NPY/AgRP Neurons Are Essential for Feeding in Adult Mice but Can Be Ablated in Neonates , 2005, Science.

[48]  M. Ghatei,et al.  Postembryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  M. Hadley.  Discovery that a melanocortin regulates sexual functions in male and female humans , 2005, Peptides.

[50]  Helgi B. Schiöth,et al.  Evolutionary conservation of the structural, pharmacological, and genomic characteristics of the melanocortin receptor subtypes , 2005, Peptides.

[51]  H. Berthoud,et al.  Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. , 2005, Endocrinology.

[52]  R. Maki,et al.  Functional Selectivity of Melanocortin 4 Receptor Peptide and Nonpeptide Agonists: Evidence for Ligand-Specific Conformational States , 2005, Journal of Pharmacology and Experimental Therapeutics.

[53]  P. Cassoni,et al.  The Oxytocin Receptor Antagonist Atosiban Inhibits Cell Growth via a “Biased Agonist” Mechanism* , 2005, Journal of Biological Chemistry.

[54]  C. Rosenblum,et al.  Activation of MAP kinase by MC4-R through PI3 kinase , 2004, Regulatory Peptides.

[55]  W. Schreibmayer,et al.  The Sensitivity of G Protein-activated K+ Channels toward Halothane Is Essentially Determined by the C Terminus* , 2004, Journal of Biological Chemistry.

[56]  J. Helms,et al.  Lipids as Targeting Signals: Lipid Rafts and Intracellular Trafficking , 2004, Traffic.

[57]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[58]  T. Gudermann,et al.  Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. , 2003, Diabetes.

[59]  J. Leaney.  Contribution of Kir3.1, Kir3.2A and Kir3.2C subunits to native G protein‐gated inwardly rectifying potassium currents in cultured hippocampal neurons , 2003, The European journal of neuroscience.

[60]  D. Segaloff,et al.  Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. , 2003, Endocrinology.

[61]  A. Daal,et al.  Melanocortins and their receptors and antagonists. , 2003, Current drug targets.

[62]  Thomas Gudermann,et al.  Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. , 2003, The Journal of clinical endocrinology and metabolism.

[63]  R. Seeley,et al.  Syndecan‐3 Modulates Food Intake by Interacting with the Melanocortin/AgRP Pathway , 2003, Annals of the New York Academy of Sciences.

[64]  S. Bloom,et al.  Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis. , 2003, Endocrinology.

[65]  S. O’Rahilly,et al.  Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. , 2003, Human molecular genetics.

[66]  A. Turnbull,et al.  Proopiomelanocortin-derived peptides in rat cerebrospinal fluid and hypothalamic extracts: evidence that secretion is regulated with respect to energy balance. , 2003, Endocrinology.

[67]  J H Wilmore,et al.  The agouti-related protein and body fatness in humans , 2003, International Journal of Obesity.

[68]  R. Przewłocki,et al.  Modulation of melanocortin-induced changes in spinal nociception by &mgr;-opioid receptor agonist and antagonist in neuropathic rats , 2002, Neuroreport.

[69]  W. Chung,et al.  The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. , 2002, The Journal of clinical investigation.

[70]  David J. Anderson,et al.  Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Gαq/11 pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Tota,et al.  The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. , 2002, European journal of pharmacology.

[72]  L. Hunyady,et al.  Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. , 2002, The Journal of endocrinology.

[73]  A. Turnbull,et al.  Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. , 2002, The Journal of endocrinology.

[74]  D. Banville,et al.  Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs , 2002, Nature Neuroscience.

[75]  P. Insel,et al.  Receptor Number and Caveolar Co-localization Determine Receptor Coupling Efficiency to Adenylyl Cyclase* , 2001, The Journal of Biological Chemistry.

[76]  R. Cone,et al.  Expression of Functional Melanocortin-4 Receptor in the Hypothalamic GT1-1 Cell Line , 2001, Neuroendocrinology.

[77]  K. Clément,et al.  Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. , 2001, The Journal of pediatrics.

[78]  G. Barsh,et al.  Transgenic Expression of Syndecan-1 Uncovers a Physiological Control of Feeding Behavior by Syndecan-3 , 2001, Cell.

[79]  H Remschmidt,et al.  Association between an agouti-related protein gene polymorphism and anorexia nervosa , 2001, Molecular Psychiatry.

[80]  W. Wilkison,et al.  Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. , 2001, Physiological genomics.

[81]  Soo-Hyun Lee,et al.  Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors. , 2001, European journal of biochemistry.

[82]  P. Sexton,et al.  Receptor activity modifying proteins. , 2001, Cellular signalling.

[83]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[84]  G. Clawson,et al.  The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. , 2000, The Journal of investigative dermatology.

[85]  P. Sexton,et al.  Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. , 2000, The Journal of pharmacology and experimental therapeutics.

[86]  J. Violin,et al.  Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. , 2000, Molecular pharmacology.

[87]  K. Kangawa,et al.  Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. , 2000, Biochemical and biophysical research communications.

[88]  P. Sexton,et al.  Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product. , 2000, Biochemical and biophysical research communications.

[89]  S. Foord,et al.  Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. , 1999, Journal of pharmacological and toxicological methods.

[90]  R. Cone,et al.  The Central Melanocortin System and Energy Homeostasis , 1999, Trends in Endocrinology & Metabolism.

[91]  M Morfis,et al.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. , 1999, Molecular pharmacology.

[92]  S. Okumura,et al.  Compartmentation of cyclic adenosine 3',5'-monophosphate signaling in caveolae. , 1999, Molecular endocrinology.

[93]  W. Born,et al.  A Receptor Activity Modifying Protein (RAMP)2-Dependent Adrenomedullin Receptor Is a Calcitonin Gene-Related Peptide Receptor when Coexpressed with Human RAMP1. , 1999, Endocrinology.

[94]  Walter Born,et al.  An Amylin Receptor Is Revealed Following Co-Transfection of a Calcitonin Receptor with Receptor Activity Modifying Proteins-1 or -3. , 1999, Endocrinology.

[95]  Ronald W. Davis,et al.  The mouse mahogany locus encodes a transmembrane form of human attractin , 1999, Nature.

[96]  P. Bork,et al.  The mahogany protein is a receptor involved in suppression of obesity , 1999, Nature.

[97]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[98]  Y. Wan,et al.  Analysis of the Gs/Mitogen-activated Protein Kinase Pathway in Mutant S49 Cells* , 1998, The Journal of Biological Chemistry.

[99]  J. Shutter,et al.  Overexpression of Agrt leads to obesity in transgenic mice , 1997, Nature Genetics.

[100]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[101]  H. Yao,et al.  cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway , 1997, Cell.

[102]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[103]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[104]  R. Cone,et al.  Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. , 1996, Endocrinology.

[105]  S. Watson,et al.  Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.

[106]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[107]  W. J. Meek,et al.  THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY. , 1938, Science.

[108]  S. O’Rahilly,et al.  Modulation of blood pressure by central melanocortinergic pathways. , 2009, The New England journal of medicine.

[109]  S. O’Rahilly,et al.  Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor. , 2009, Endocrinology.

[110]  A. von Deimling,et al.  A role for beta-melanocyte-stimulating hormone in human body-weight regulation. , 2006, Cell metabolism.

[111]  G. Milligan,et al.  The role of GPCR dimerisation/oligomerisation in receptor signalling. , 2006, Ernst Schering Foundation symposium proceedings.

[112]  R. Lefkowitz,et al.  Seven-transmembrane receptor signaling through beta-arrestin. , 2005, Science's STKE : signal transduction knowledge environment.

[113]  F. Rüschendorf,et al.  Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2 , 2005, Nature Genetics.

[114]  R. Cone,et al.  The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. , 2004, Recent progress in hormone research.

[115]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[116]  R. Adan,et al.  AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. , 2001, Molecular endocrinology.

[117]  G. Barsh,et al.  Characterization of Agouti-related protein binding to melanocortin receptors. , 1999, Molecular endocrinology.